Table 2. Clinical characteristics of PCOS and control subjects.
| Clinical characteristics | PCOS (n=6) | Normal (n=6) | P value |
|---|---|---|---|
| Age (year) | 30.33±3.98 | 31.5±5.05 | 0.666 |
| BMI (kg/m2) | 24.92±2.46 | 21.17±2.42 | 0.022 |
| W (cm) | 77±4.52 | 73.33±2.73 | 0.120 |
| H (cm) | 93.5±3.67 | 89.83±2.28 | 0.063 |
| FSH (mIU/mL) | 5.218±1.01 | 3.973±1.23 | 0.084 |
| E2 (pg/mL) | 42.11±16.04 | 43.06±18.07 | 0.925 |
| P (ng/mL) | 0.7683±0.33 | 0.56±0.26 | 0.258 |
| PRL (ng/mL) | 9.918±3.86 | 8.807±0.83 | 0.506 |
| LH (mIU/mL) | 7.442±4.44 | 2.095±0.98 | 0.016 |
| T (ng/mL) | 1.785±1.04 | 1.63±0.41 | 0.742 |
| β-HCG (mIU/mL) | 1.017±0.54 | 0.425±0.68 | 0.127 |
| Fasting glucose (mmol/L) | 5.085±0.40 | 5.035±0.29 | 0.808 |
All data are presented as the mean ± SEM. P<0.05 was considered significant. PCOS, polycystic ovary syndrome; BMI, body mass index; W, waist circumference; H, hip circumference; FSH, follicle stimulating hormone; E2, estrogen; P, progesterone; PRL, prolactin; LH, luteinizing hormone; T, testosterone; β-HCG, Human chorionic gonadotropin β.